In another study, Duan Wenhu et al. [152] also described and screened a compound targeting IRAK4, PROTAC 48 (Table 2), which induces IRAK4 degradation in diffuse large B-cell lymphoma OCILY10 and TMD8 cells. Here, IRAK4 is linked to diffuse large B-cell lymphoma.